CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.: basic weighted-average shares
Basic weighted-average shares for CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC. financial histories
What this measure means
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
Exact concept: us-gaap:WeightedAverageNumberOfSharesOutstandingBasic. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2022-06-01 to 2025-05-31. The SEC response was captured on 2026-09-20.
Reading these values
This selected numerical history matches Diluted weighted-average shares for the same reporting intervals and original units. The accounting definitions remain distinct. Equal values do not establish that the concepts are interchangeable or explain why they match; filing dates and accessions may differ. Compare the definitions and source filings before combining them.
Context from the filing
Cannabis Bioscience International Holdings' fiscal years end May 31. Its 2024 and 2025 filing reports full dollar losses and share counts, with EPS of -$0.00006 and -$0.00005, respectively; these small per-share losses are not zero income. The filing states that there were no dilutive securities at the two year-end dates. That statement does not establish that no potentially convertible instruments existed or approve earlier years. Read the source filing.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| 2024-06-01 | 2025-05-31 | 10,716,352,087 | shares | 2025-09-22 | 10-K · 0001683168-25-007174 |
| 2023-06-01 | 2024-05-31 | 10,317,612,225 | shares | 2025-09-22 | 10-K · 0001683168-25-007174 |
| 2022-06-01 | 2023-05-31 | 9,001,539,324 | shares | 2024-09-16 | 10-K · 0001683168-24-006402 |
Related financial histories
- CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.: total assets
- CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.: total liabilities
- CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.: stockholders equity
- CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.: net income or loss
- CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.: operating cash flow
- CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.: revenue
- CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.: financing cash flow
- CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.: retained earnings or deficit
- CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.: diluted weighted-average shares
- CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.: basic earnings per share
- CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.: diluted earnings per share
- CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.: operating income or loss
- CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.: current assets
- CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.: current liabilities
- CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.: net current accounts receivable
- CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.: operating expenses
- CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.: gross profit
- CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.: cost of revenue
Inspect the source
- Entity
- CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC. / CIK 0001411057
- Captured
- 2026-09-20T08:01:51.094Z
- SEC response SHA-256
65039acad959501dea2ae2bfec13b3503da3ac05045712ff74cd71cfd51e2523
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001411057.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))